NMT2

Glycylpeptide N-tetradecanoyltransferase 2 · O60551 · NMT2 on Sugi Atlas →

10,276 patent compounds predicted against NMT2, 4,565 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3470768 SCHEMBL3470768 1.00 18/20
SCHEMBL3472005 SCHEMBL3472005 1.00 18/20
SCHEMBL3473477 SCHEMBL3473477 1.00 18/20
SCHEMBL3472011 SCHEMBL3472011 0.83 18/20
SCHEMBL3471351 SCHEMBL3471351 0.81 18/20
SCHEMBL3470345 SCHEMBL3470345 0.81 18/20
SCHEMBL3472069 SCHEMBL3472069 0.80 18/20
SCHEMBL3475814 SCHEMBL3475814 0.77 18/20
SCHEMBL3476799 SCHEMBL3476799 0.76 18/20
SCHEMBL3470753 SCHEMBL3470753 0.72 18/20
SCHEMBL3472706 SCHEMBL3472706 0.68 18/20
SCHEMBL3472004 SCHEMBL3472004 0.63 18/20
SCHEMBL3472756 SCHEMBL3472756 0.62 18/20
SCHEMBL3472759 SCHEMBL3472759 0.58 18/20
SCHEMBL3473958 SCHEMBL3473958 0.52 18/20
SCHEMBL3475905 SCHEMBL3475905 0.79 17/20
SCHEMBL3472236 SCHEMBL3472236 0.76 17/20
SCHEMBL3472573 SCHEMBL3472573 0.75 17/20
SCHEMBL3476012 SCHEMBL3476012 0.74 17/20
SCHEMBL3475864 SCHEMBL3475864 0.70 17/20

Clinical trials — most relevant to NMT2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) PHASE2/PHASE3COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer PHASE1/PHASE2COMPLETED
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine EARLY_PHASE1COMPLETED
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression nanCOMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) nanRECRUITING
NGLY1 Natural History nanCOMPLETED
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery nanNOT_YET_RECRUITING
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation nanCOMPLETED
Identification and Characterization of Monogenic Diabetes nanCOMPLETED
Genome Environment Microbiome and Metabolome in Autism Study nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) nanRECRUITING
MYT1L Syndrome: a Rare Paediatric Genetic Syndrome Responsible for a Neurodevelopmental Disorder nanRECRUITING
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Evaluation of Blood Protein O-GlcNAcylation Levels in Children nanRECRUITING
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam nanUNKNOWN
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Cross-Sectional and Longitudinal Studies of Pre-Diabetes in the Pima Indians nanCOMPLETED
Predisposition Genes in Monogenic Diabetes (DIAMONO) nanCOMPLETED
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NMT2 binder may also engage these)

ProteinNameSimilarity
Q9N181 1.000 Q9N181 →
P31717 1.000 P31717 →
Q5RAF3 1.000 Q5RAF3 →
A7YT82 1.000 A7YT82 →
NMT1 Glycylpeptide N-tetradecanoyltransferase 1 0.998 landscape →
Q8K1Q0 0.997 Q8K1Q0 →
O70311 0.997 O70311 →
O70310 0.995 O70310 →
O61613 0.994 O61613 →
Q9LTR9 0.993 Q9LTR9 →
NAT10 RNA cytidine acetyltransferase 0.985 landscape →
Q75EK2 0.984 Q75EK2 →
Q803R5 0.983 Q803R5 →
Q5R981 0.982 Q5R981 →
Q4KLT3 0.982 Q4KLT3 →
Q8N1G2 0.982 Q8N1G2 →
O74234 0.981 O74234 →
P46548 0.981 P46548 →
Q5U2Z5 0.980 Q5U2Z5 →
Q9DBC3 0.980 Q9DBC3 →
Q5ZJM3 0.980 Q5ZJM3 →
Q5XHF8 0.980 Q5XHF8 →
Q8TFN1 0.980 Q8TFN1 →
F4J8C6 0.979 F4J8C6 →
Q6GQ76 0.979 Q6GQ76 →
Q4KWH8 0.978 Q4KWH8 →
A7Z050 0.978 A7Z050 →
B3M1E1 0.978 B3M1E1 →
P97386 0.978 P97386 →
P14743 0.978 P14743 →